DrugNews: Court Update Shows Rise in Yaz Lawsuits

Share Article

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

YAZ LAWSUIT
Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugNews Center or speak with a lawyer about their options.

The birth control safety center at DrugNews.net is announcing updated information for women who’ve taken the drugs Yaz or Yasmin. The latest court records show the number of lawsuits alleging Yaz side effects has risen slightly although the manufacturer continues to settle claims*.

DrugNews is a free resource for those using popular prescription drugs or medical devices. By learning about the latest safety alerts, recalls, studies and legal news, patients can avoid potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.

Due to the number of patients who have already filed a Yaz lawsuit alleging side effects, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).

The resource center has added information showing the maker of the drugs, Bayer, has spent approximately $1.4 billion so far to settle claims alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****.

Now, DrugNews has learned the latest report from the Judicial Panel on Multidistrict Litigation shows the number of pending claims has risen slightly from 9,838 on September 11th to 9,873 on October 17*.

Lawyers are still helping those affected. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugNews Center or speak with a lawyer about their options.

Due to the complexity of federal MDL cases, patients should seek a lawyer with experience in defective drug litigation. DrugNews only recommends lawyers who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.

*JPML 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter Q2, Explanatory Notes, Legal Risks, 7/31/13; stockholders-newsletter-q2-2013.bayer.com/en/explanatory-notes.aspx

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugNews
888-987-4866
Email >
Visit website